Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males

Brain Dev. 1995 Sep-Oct;17(5):317-21; discussion 323-4. doi: 10.1016/0387-7604(95)00031-6.

Abstract

A rapid screening test was developed to detect CGG repeat expansion of the FMR-1 gene causing the fragile X syndrome by a non-radioisotope PCR technique. A biotin-labeled primer was initially used and the biotin-labeled PCR product was detected by means of chemiluminescence. The normal PCR product of around 300 bp was not created in the abnormal FMR-1 gene sample with this method. Four positive samples were found among those from 226 mentally retarded males, but the CGG repeat expansion was shown on Southern blot analysis in only one sample. To eliminate false-positive samples, a hybridization method involving a biotin-labeled (CGG)s oligonucleotide was developed for the PCR product and the CGG repeat expansion could be detected. Finally, 256 mentally retarded males in Japan were examined and only 2 abnormal samples were detected. The prevalence of this abnormality was less than 1%, which is relatively lower than those reported previously.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Blotting, Southern
  • Child
  • DNA / analysis*
  • Female
  • Fragile X Syndrome / diagnosis*
  • Fragile X Syndrome / epidemiology
  • Fragile X Syndrome / genetics
  • Humans
  • Intellectual Disability / diagnosis*
  • Intellectual Disability / epidemiology
  • Intellectual Disability / genetics
  • Japan / epidemiology
  • Luminescent Measurements
  • Male
  • Molecular Sequence Data
  • Pedigree
  • Polymerase Chain Reaction
  • Repetitive Sequences, Nucleic Acid

Substances

  • DNA